AU3076600A - 3,7-disubstituted indole derivatives and medicinal compositions containing the same - Google Patents

3,7-disubstituted indole derivatives and medicinal compositions containing the same

Info

Publication number
AU3076600A
AU3076600A AU30766/00A AU3076600A AU3076600A AU 3076600 A AU3076600 A AU 3076600A AU 30766/00 A AU30766/00 A AU 30766/00A AU 3076600 A AU3076600 A AU 3076600A AU 3076600 A AU3076600 A AU 3076600A
Authority
AU
Australia
Prior art keywords
same
compositions containing
indole derivatives
medicinal compositions
disubstituted indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30766/00A
Inventor
Hiroshi Harada
Shiro Kato
Hitoshi Kawashima
Ikuko Taoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of AU3076600A publication Critical patent/AU3076600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AU30766/00A 1999-01-29 2000-01-24 3,7-disubstituted indole derivatives and medicinal compositions containing the same Abandoned AU3076600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP02148399A JP2003055344A (en) 1999-01-29 1999-01-29 3,7-disubstituted indole derivative and medicinal composition including the same
JP11/21483 1999-01-29
PCT/JP2000/000316 WO2000044721A1 (en) 1999-01-29 2000-01-24 3,7-disubstituted indole derivatives and medicinal compositions containing the same

Publications (1)

Publication Number Publication Date
AU3076600A true AU3076600A (en) 2000-08-18

Family

ID=12056233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30766/00A Abandoned AU3076600A (en) 1999-01-29 2000-01-24 3,7-disubstituted indole derivatives and medicinal compositions containing the same

Country Status (3)

Country Link
JP (1) JP2003055344A (en)
AU (1) AU3076600A (en)
WO (1) WO2000044721A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002038544A2 (en) 2000-11-10 2002-05-16 Eli Lilly And Company 3-substituted oxindole beta 3 agonists
DE60211199T2 (en) * 2001-08-14 2007-02-01 Eli Lilly And Co., Indianapolis 3-SUBSTITUTED OXINDOL BETA-3 AGONISTS
WO2003016307A1 (en) 2001-08-14 2003-02-27 Eli Lilly And Company β3 ADRENERGIC AGONISTS
ES2242890T3 (en) 2001-11-20 2005-11-16 Eli Lilly And Company BETA 3 AGONISTS OF OXINDOL 3-REPLACED.
JP2005518357A (en) 2001-11-20 2005-06-23 イーライ・リリー・アンド・カンパニー Beta 3 adrenergic agonist
WO2003059348A1 (en) 2002-01-11 2003-07-24 Eli Lilly And Company 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601008B1 (en) * 1986-07-03 1990-03-30 Sanofi Sa PROCESS FOR THE STEREOSPECIFIC SYNTHESIS OF INDOLE DERIVATIVES
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
AU1034195A (en) * 1994-11-17 1996-06-17 Dainippon Pharmaceutical Co. Ltd. 2-{2-(indol-3-yl)ethylamino}-1-phenylethanol derivative
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists

Also Published As

Publication number Publication date
JP2003055344A (en) 2003-02-26
WO2000044721A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
EG24066A (en) Novel quinuclidine derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL202633A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
IL145012A0 (en) Fluorine substituted triarylmethane derivatives and pharmaceutical compositions containing the same
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
IL137415A0 (en) Cyclobutene derivatives and pharmaceutical compositions containing the same
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0102400A3 (en) Substituted octalydropyrido[1,2a]pyrazin derivatives and pharmaceutical compositions containing the same
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
HUP0200088A3 (en) Pyridazin-3-one derivatives and pharmaceutical compositions containing the same
HUP0201338A3 (en) Novel indole derivatives, pharmaceutical compositions containing them and their use
AU2001294240A1 (en) 2,2-diphenylbutanamide derivatives and medicines containing the same
AU6229099A (en) Dihydropyridine derivatives and drug compositions containing the same
HUP0203767A3 (en) Novel indole derivatives, pharmaceutical compositions containing them and their use
AU3076600A (en) 3,7-disubstituted indole derivatives and medicinal compositions containing the same
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase